SAB Biotherapeutics (SABS)

SAB Biotherapeutics (SABS) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.

• SABS last traded at $3.19, 8.50% on the day.
• SAB Biotherapeutics: market cap $287.38M, P/E -3.3, revenue $1.63M over the last four quarters.
• Over the past year SABS returned 0.31%; year to date -14.71%.

Updated 2026-11-07 12:02 UTC